NeuroTexas Institute, St. David's HealthCare, Austin, USA.
J Neurosurg Spine. 2013 Sep;19(3):301-6. doi: 10.3171/2013.5.SPINE12992. Epub 2013 Jun 28.
The authors comprehensively studied the recovery of individual patients undergoing treatment for lumbar disc herniation. The primary goal was to gain insight into the variability of individual patient utility scores within a treatment cohort. The secondary goal was to determine how the rates and variability of patient recovery over time, represented by improvement in utility scores, affected long-term patient outcomes.
EuroQol Group-5 Dimension (EQ-5D) scores were obtained at baseline and at 2, 4, 8, 12, 26, 38, and 52 weeks for 93 patients treated under a prolonged conservative care protocol for lumbar disc herniation. Gaussian kernel densities were used to estimate the distribution of utility scores at each time point. Logistic regression and multistate Markov models were used to characterize individual patient improvement over time. Fisher exact tests were used to compare the distribution of EQ-5D domain scores.
The distribution of utility scores was bimodal at 1 year and effectively sorted patients into a "higher" utility group (EQ-5D = 1; 43% of cohort) and a "lower" utility group (EQ-5D ≤ 0.86; 57% of cohort). Fisher exact tests revealed that pain/discomfort, mobility, and usual activities significantly differed between the 2 utility groups (p ≪ 0.001). The utility groups emerged at 8 weeks and were stable for the remainder of the treatment period. Using utility scores from 8 weeks, regression models predicted 1-year outcomes with 62% accuracy.
This study is the first to comprehensively consider the utility recovery of individual patients within a treatment cohort for lumbar disc herniation. The results suggest that most utility is recovered during the early treatment period. Moreover, the findings suggest that initial improvement is critical to a patient's long-term outcome: patients who do not experience significant initial recovery appear unlikely to do so at a later time under the same treatment protocol.
作者全面研究了接受腰椎间盘突出症治疗的个体患者的康复情况。主要目的是深入了解治疗队列中个体患者效用评分的可变性。次要目标是确定患者在治疗期间随时间推移的恢复率和可变性(以效用评分的改善来表示)如何影响长期患者结局。
93 名接受腰椎间盘突出症长期保守治疗方案治疗的患者,在基线时以及治疗后第 2、4、8、12、26、38 和 52 周时,分别记录欧洲五维健康量表(EQ-5D)评分。使用高斯核密度估计每个时间点的效用评分分布。使用逻辑回归和多状态马尔可夫模型来描述个体患者随时间的改善情况。使用 Fisher 确切检验比较 EQ-5D 各维度评分的分布。
效用评分的分布在 1 年时呈双峰分布,有效地将患者分为“较高”效用组(EQ-5D=1;队列的 43%)和“较低”效用组(EQ-5D≤0.86;队列的 57%)。Fisher 确切检验显示,2 个效用组之间的疼痛/不适、移动性和日常活动评分存在显著差异(p≪0.001)。效用组在 8 周时出现,在治疗期间的其余时间保持稳定。使用 8 周时的效用评分,回归模型对 1 年结局的预测准确率为 62%。
这项研究首次全面考虑了腰椎间盘突出症治疗队列中个体患者的效用恢复情况。结果表明,大多数效用在治疗早期恢复。此外,研究结果表明,初始改善对患者的长期结局至关重要:在相同的治疗方案下,没有经历显著初始恢复的患者,后期不太可能恢复。